Diabetes Insights - Breakthroughs and Innovators

• The Future of Diabetes Technology: Beyond Devices to Equity and Personalisation

  In this special episode, host Vivienne Parry is joined by experts Anna Krook (Karolinska Institute), Klemen Dovč (Ljubljana University Medical Centre), Peter Gillard (University Hospital Leuven), and Julia Mader (University of Graz) to explore the rapid evolution of diabetes technology. From continuous glucose monitors (CGMs) and automated insulin delivery (AID) systems to AI-powered apps and integrated health records, the panel discusses how these innovations are transforming care and what barriers remain. They unpack emerging trends in personalisation, device standardisation, and the urgent need for equitable access to ensure no one is left behind. The conversation draws on insights from Diabetologia’s 60th Anniversary Technology Supplement and Symposium (the official journal of the EASD), along with reflections from people living with diabetes themselves. The panel also explores a central question: how do we ensure everyone, from preschoolers to older adults, in both urban and rural settings, can benefit from these technologies? Tune in to hear what’s next for diabetes tech, and why centring people with diabetes in innovation is critical.

  --------  

  11:54

  --------

  11:54
• Can Pre-Diabetes Remission Reduce Global Diabetes Incidences?

  In this episode, Dr Andreas Birkenfeld (Germany) and Dr Viswanathan Mohan, 1st EASD Diabetes Global Impact Prize winner (India), join host Vivienne Parry to explore the growing importance of recognising, screening and managing pre-diabetes on a global scale. They discuss how moving beyond diabetes remission to pre-diabetes remission could prevent long-term complications, and why strategic, risk-based screening could ease the economic burden on health systems. From policy change and health economics to public awareness and culturally tailored approaches, this episode highlights why proactive intervention in pre-diabetes is critical and what it will take to make it happen worldwide.

  --------  

  11:29

  --------

  11:29
• What Will the Future Bring for People Living with Diabetes?

  What does the future hold for people living with diabetes? In this episode, our host Vivienne Parry together with diabetes advocates Bastian Hauck, Renza Scibilia and Christian Collin dives into recent advances in diabetes prevention, screening, and therapeutics - from GLP-1 drugs to innovative community-driven screening strategies. But as science accelerates, can our health systems and societies keep up? Join us for an eye-opening conversation on equity, access, and the power of community in reshaping diabetes care.

  --------  

  19:46

  --------

  19:46
• Will Next Generation Obesity Drugs make Bariatric Surgery Obsolete?

  In this lively episode of Diabetes Insights, Prof. Francesco Rubino (King’s College London) and Dr. Louis Aronne (Weill Cornell Medicine) join Vivienne Parry to debate one of the biggest questions in obesity care: will next-generation medications make bariatric surgery obsolete? Drawing on decades of clinical experience and new trial evidence, they explore whether powerful GLP-1-based therapies and combination drugs can rival the life-changing outcomes of surgery. From costs and complications to patient preferences and the hidden biology of obesity, they unpack how a new era of multi-modal treatment is reshaping care. 🎧 Tune in for sharp insights, respectful disagreement and a glimpse into the future of integrated obesity management. #diabetes #Obesity #GLP1 #BariatricSurgery #Podcast

  --------  

  11:16

  --------

  11:16
• Breaking Barriers: Public-Private Partnerships Revolutionizing Diabetes Research

  In this episode, Dr. Melissa Thomas (Eli, Lilly & Company), Dr. Elizabeth Niemoller (Sanofi) and Prof. Michele Solimena (Helmholtz Zentrum München & Technical University of Dresden) join host Vivienne Parry to examine how partnerships between academia and industry are transforming diabetes research and care. They discuss the culture shift from cautious collaboration to dynamic, mission-driven partnerships and how initiatives like INNODIA and the Innovative Medicines Initiative (IMI) are delivering real progress for patients. From translational breakthroughs to embedding patient advocates in clinical trial design, they explore why diverse perspectives, early regulatory foresight and shared goals are essential to accelerating therapeutic innovation. 🎧 Listen now for an insider’s look at how public-private partnerships are redefining diabetes science.

  --------  

  20:47

  --------

  20:47

Weitere Bildung Podcasts

Trending Bildung Podcasts

Über Diabetes Insights - Breakthroughs and Innovators